Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : IMMODULON THERAPEUTICS LTD
Femme et Homme Max 99 ans
IMMODULON THERAPEUTICS LTD
MAJ Il y a 4 ans
A Phase II Study Comparing the effects of Gemcitabine with and without IMM-101 in Advanced Pancreatic Cancer Studio di fase II finalizzato a confrontare gli effetti della Gemcitabina con e senza IMM-101 nel Carcinoma Pancreatico Avanzato
No clinically relevant deleterious effect of IMM-101 on safety and tolerability profiles as judged by: • Local and systemic toxicities. • Number, type and degree of toxicities as measured by the NCI...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
IMMODULON THERAPEUTICS LTD
MAJ Il y a 4 ans
IMM101 treatment, combined with CyberKnife, in Colorectal Cancer
To investigate the efficacy of IMM-101 in combination with radiation induced tumour necrosis (induced by CyberKnife treatment) in patients with colorectal cancer with metastatic disease who have recei...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
IMMODULON THERAPEUTICS LTD
MAJ Il y a 4 ans
A Study of IMM 101 in combination with various standard cancer treatments in patients with advanced cancer or cancer which cannot be removed by surgery
The primary objective of the study is to provide safety data for IMM 101 in combination with a number of selected chemotherapy regimens
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations